Mast Reforestation Has a Major Month in May

Mast Reforestation, formerly Droneseed, had an exciting month which began with the securement of its $15 million financing agreement with Carbon Streaming Corporation. The partnership will advance its post-wildfire reforestation projects throughout the American West. This first-of-its-kind project financing will cover the high upfront costs of reforestation projects, accelerating Mast's forest restoration work and enabling the company to serve more landowners affected by wildfires.

"This innovative project financing is a scalable model that will help us get more trees in the ground, accelerating reforestation efforts in areas devastated by the rise in forest fires amplified by climate change," said Mast CEO and Founder, Grant Canary. Mast Reforestation's Chief Revenue Officer, Woolsey McKernon, describing the selection process stated, "Carbon Streaming has a proven track record of supporting projects in the nature-based voluntary carbon markets. Given that and our shared vision for scaling reforestation and carbon removal solutions, we feel this partnership is an ideal match."

In other news, Mast Reforestation was named to CNBC’s Disruptor 50 List. CNBC highlights private companies that are chasing some of the market’s biggest opportunities, and growing despite a tough capital markets environment and slowing economy.

For more information on Mast Reforestation, follow here.

Karin O’Connor, Hypercell’s Bruno Jactel Represent Serra at Future-of-Food Event

The second annual Future of Food event was held in Chicago as part of the Chicago Venture Summit on May 4 and had strong representation from Team Serra. The event was a sold-out show with over 700 attendees.

Karin O’Connor, venture partner with Serra, was a spotlight speaker at the event. Bruno Jactel, the CEO of Hypercell Technologies, a Serra Ag Tech Fund company, also was a featured presenter. Also in attendance was Jack Marck, Managing Director of the Illinois Ag Tech Accelerator Powered by Serra Ventures, and Drew Beard, Associate with Serra Ventures.

In addition to the great team representation at the Future of Food, Serra proudly provided significant financial sponsorship. "This unique, high energy event showcased many of the exceptional companies and teams that comprise the Ag Tech and Agrifood ecosystem here in Illinois," commented Karin O'Connor. "We are privileged to participate and offer continued sponsorship of this conference."

For more on the story, follow here.

Cardea Bio Acquired by Paragraf

The Serra team is very pleased to announce the acquisition of portfolio company Cardea Bio on May 2, 2023.

In a first for the graphene electronics industry, leading integrated device manufacturer Paragraf is acquiring graphene biosensor market pioneer Cardea Bio to accelerate the mass production of a new generation of devices that will deliver real-time analysis in point-of-need tests in the agritech, healthcare and environmental monitoring spaces.

Cardea is a Serra Capital II and Serra Capital II Follow-On-Fund company, with an initial investment made in April of 2015.

“Joining Paragraf allows us to use the world’s only mass-produced, transfer-free monolayer graphene to manufacture the state-of-the art graphene-based biosensors developed by the Cardea team over the last ten years. We are looking forward to unlocking powerful synergistic effects to advance the broad and growing use of graphene biosensors for the benefit of both people and the planet” said Michael Heltzen, EVP of Strategy at Paragraf USA (former CEO and co-founder of Cardea Bio).

To view the full press release, follow here.

VeriSim Life Partners with Clarivate

VeriSIM Life, the leading artificial intelligence (AI)-enabled, unique R&D decisions de-risker for breakthrough drug development, this week announced a partnership with Clarivate, a global leader in connecting people and organizations to intelligence they can trust.

The partnership will improve pre-clinical success rates by leveraging VeriSim’s AI drug decision engine and R&D drug discovery intelligence platform from Clarivate. VeriSim is a Serra Capital III and Serra III SBIC company.

To view the full article, follow here.

Myagi Acquired by Rallyware

Serra is excited to announce the acquisition of Myagi, Inc. by Rallyware Q1 of 2023. Myagi is a Serra Capital III and Serra Capital III (SBIC) portfolio company, with the first investment made in October, 2018.

Rallyware has developed a unique software solution for measuring the performance of distributed workforces in retail environments. Myagi's software helps that same workforce be more productive by providing just-in-time training on specific products. The combination of the two companies creates a complete solution for retail companies to improve and measure their workforce across multiple locations.

Rob Schultz, Managing Partner at Serra, commented, "We are thrilled for Simon Turner, CEO, and his team as Myagi combines with Rallyware, a company backed by Peakstone Capital. This is a win for the customers of the combined entities, the employee teams and the investors. Serra is proud to have been one of the major investor-partners of Myagi in its journey."

To view the full press release, follow here.

Zerigo Health Launches Digital Platform for At-Home Treatment

Zerigo Health, a Serra Capital III portfolio company that has created an at-home smart light therapy solution, made a major announcement this week that it was launching the Zerigo 2.0 ecosystem - a digital platform that connects health care systems and patients to the management and phototherapy treatment of chronic skin conditions such as eczema and psoriasis.

“The American Academy of Dermatology has published guidelines that show phototherapy is safe and effective for psoriasis and eczema,” Frank D. D’Amelio, chief operating officer and interim CEO of Zerigo Health, told Healio. “However, it is really inconvenient for patients to come into the physician’s office two to three times a week for 12 weeks.

To view the full press release, follow here.

Announcing Elate’s Series A Round of Funding: Serving Strategy and Operations Leaders

Elate, a Serra Capital III SBIC portfolio company, has announced its $4.9M Series A funding round. The most recent round will help empower organizations to push forward their strategic planning, strategy, and dynamic planning efforts. Serra is a proud participant in the round.

To view the complete announcement, follow here.

Combyne Acquired by Bayer

Serra Ventures is pleased to announce that Serra Capital III company Combyne has been acquired by Bayer. The grain marketing app company has been acquired by Bayer Crop Science, joining Bayer’s suite of digital tools for farmers. Combyne was known as FarmLead until 2020, and will continue to operate at arms-length to Bayer’s broader business, while benefiting from added resources and association with a partner with a shared vision.

To view the complete article, follow here.

Previously Unachievable Drug Discovery Insights Created by Cardea Bio's BPU Platform

Cardea Bio, a Serra Capital II company, announced this week that it had reached a pivotal milestone, with its first external partner beginning the use of the BPU (Biosignal Processing Unit) platform. This platform is essential in the advancement of drug discovery research and will produce new and highly sought-after insights.

Cardea’s focus is creating products and applications that enable precision healthcare by improving diagnostic ease, speed, and cost. It is the first company to combine expertise in biology, nanotechnology, surface chemistry, engineering, and manufacturing to create practical and scaleable graphene biological field effect transistor (BioFET) products.

To view the complete article, follow here.

Serra Capital III SBIC Company Ryvit Acquired by Trimble

Ryvit, the integration Platform-as-a-Service provider for the construction industry, announced this week that it has been acquired by Trimble. Trimble is an industrial technology company transforming the way the world works by delivering solutions that enables customers to thrive. The acquisition will accelerate and expand Trimble’s connected construction workflows.

“Ryvit has been relentlessly focused on transforming the construction industry into a more productive and profitable industry powered by data,” said Tom Stemm, chief executive officer of Ryvit. "Over the past seven years, we’ve done this by building a platform that connects data between some of the industry’s largest technology providers to improve efficiency and streamline workflows for construction. Trimble is similarly focused on becoming an industry-leading open platform provider so this acquisition is a perfect match for both companies, who share a similar mission and vision for the industries we serve.”

Serra invested in Ryvit 2019.

Amazon Web Services picks Conservation Labs for placement in national city infrastructure accelerator for startups

Amazon Web Services Inc., a cloud computing platform subsidiary of Amazon.com Inc., has chosen Conservation Labs Inc. to be among nine startups across the country to participate in the AWS Sustainable Cities Accelerator for Infrastructure. This program will provide Conservations Labs with access to technical, business, and mentorship opportunities.

The Pittsburgh-based company offers a powerful water-saving solution, H2know, which translates the sound of water in standard building pipes into usable information like flow rate, classification of use and leak likelihood. With water the second largest energy expenditure in U.S. buildings, Conservation Labs' offering is resonating with major restaurant brands, commercial laundry entities, insurance companies and real estate developers.

Conservation Labs is a Serra Capital III SBIC portfolio company.

Opendorse Raises $20M in Latest Funding Round

December was a big month for Serra company Opendorse, and it is not over yet. The company announced that it has raised $20M in its latest funding round, in which Serra Ventures participated. Opendorse says it will use the capital to meet its ever-increasing demand for advancing NIL platforms.

Opendorse was also featured in Sports Illustrated this week, accounting that it had launched its new “NIL Book,” which will help athletes navigate what they can expect from the platform, including earning expectations.

With new schools joining up with Opendorse daily, things will not be slowing down for this company any time soon.

VeriSIM Life Named “Predictive Analytics Solution of the Year” by BioTEch Breakthrough

VeriSIM Life, a Serra portfolio company in Serra III and SBIC, made an exciting announcement the first week of November that they had received the honor of being named “Predictive Analytics Solution of the Year” in this year’s BioTech Breakthrough Awards. Biotech Breakthrough is a leading independent market intelligence organization that evaluates and recognizes standout life sciences and biotechnology companies, products, and services around the globe.

VeriSIM Life is the leading artificial intelligence (AI)-enabled unique R&D decisions de-risker for breakthrough drug development. "We are honored to receive this award from BioTech Breakthrough,” said Dr. Jo Varshney, CEO of VeriSIM Life. “Being named Predictive Analytics Solution of the Year validates our recent BIOiSIM platform innovations. Technologies like our unique Translational Index™, which synthesizes the potential for clinical success of any drug candidate, enable smarter decisions about how to advance asset programs and ultimately improve the lives of patients in need.”

View the entire article here.

Vytelle a Sustainability Leadership Award winner

Vytelle, a Serra Ag Tech Fund portfolio company, recently received a special award for global sustainability. The Business Intelligence Group named Vytelle a Sustainability Leadership Award winner in the 2022 Sustainability Awards program. The Sustainability Awards honor those people, teams and organizations who have made sustainability an integral part of their business practice or overall mission.

Vytelle is developing genetic data and IVF technologies for cattle breeding.

To view the entire article, follow here.

Three Serra companies named to Inc. 5000 Fastest-Growing Company List

In the month of August, Serra companies Built In Chicago, Wrapify, and Paystand, were all named to the prestigious Inc 5000 list which recognizes the country’s fastest growing companies. This is the third time both Paystand and Wrapify have made the list in recent years. The team at Serra is proud to have these companies recognized for their growth, especially in light of the recent economic state.

The complete results of the Inc. 5000, including company profiles, can be found at www.inc.com/inc5000.

Paystand Acquires Yaydoo

Paystand, the company that is changing B2B payments with a modern infrastructure built on SaaS, announced this week that it had acquired Yaydoo, one of Mexico’s 100 fastest growing startups. The acquisition comes amidst general economic uncertainty and a downcast Fintech environment, opening up a horizon of hope and opportunity, not only for other tech startups but also for Latin American businesses.

Jeremy Almond, CEO of Paystand shared “There is a significant market opportunity in front of Paystand and Yaydoo. With its scale, the combined company could be on a path to an Initial Public Offering (“IPO”) in the next 2 years, re-opening IPO capital access to the tech sector that is struggling in a recession-prone environment.”

Opendorse Launches NIL Marketplace for Fans

Just this week, Opendorse made a major announcement that it has launched online NIL Marketplace for fans. This will allow fans to financially support athletes through name, image and likeness deals by a few simple clicks. At Opendorse.com, school-specific pages will be available for universities that partner with the company. Through those pages, users can access athletes' profiles with rates for various services.“Collectives have dominated conversations about NIL, but where are the fans in that conversation?” Opendorse CEO Blake Lawrence said, “It’s really to help sports fans: This is where you go, this is what you do and this is what it costs.”

It has been one full year since college sports changed forever, with thousands of athletes being able to benefit from NIL. The first year of the NIL era reached a total of $917M according to Opendorse data, and there is no doubt year two will reach over $1B. 

OnRamp AgTech Conference Held in Champaign; Serra a Presenting Sponsor

The last week of July marked the much anticipated OnRamp Agriculture Conference, which was attended by nearly 400 guests. The third annual run of this event, the conference was an exciting opportunity for the Champaign-Urbana community, being the first to host it in person, and bringing the industry’s leading corporations, startups and investors together all in the name of celebrating the future of Ag.

The event kicked off on Monday evening with a dinner and keynote presentation, with Serra CEO Tim Hoerr acting as emcee. The following day was the all-day event, consisting of several talks, a keynote presentation, tours, and afternoon meetings where investors and companies could connect.

Rob Schultz, Managing Partner with Serra, hosted a talk on Tip, Trends and Traps in the Ag space. It was a tremendous experience, exploring and learning from business and industry leaders in the Ag space. Serra Ventures is proud to have been a presenting sponsor of this event.

Artio Medical Closes $28M in Additional Series A Financing

Artio Medical, Inc., the medical device company that is developing innovative products for the peripheral vascular, neurovascular, and cardiology markets, announced this week the closing of $28 million in oversubscribed Series A2 and Series A3 financing. This brings the total amount raised to date to $74 million.

Artio is a Serra Capital III and Serra Capital III SBIC company.

VeriSIM Life, Total Brain to develop drugs for broad range of neurological disorders

VeriSIM Life, a Serra Capital company, announced this week that it was partnering with Total Brain to develop new drugs for the treatment of a wide array of neurological disorders. This collaboration will integrate VerisSIM’s BIOSIM artificial intelligence-enabled drug development decision engine with Total Brain’s mental health and brain performance database to develop new therapies.

“We are excited to partner with Total Brain to combine the power of their high-dimensional data with our drug prediction engine to open new doors for drug discovery specifically addressing neurological conditions — something that has never been explored this way before,” Jo Varshney, PhD, founder and CEO of VeriSIM Life.